Evidence map›Paper›PMID 32817217›Full record

ArticleJournal of virology2020

Probing the Structure of the HIV-1 Envelope Trimer Using Aspartate Scanning Mutagenesis.

Raksha Das, Rohini Datta, Raghavan Varadarajan

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. A facile method of mapping HIV-1 neutralizing epitopes using chemically masked cysteines and deep sequencing.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Raksha DasMolecular Biophysics Unit, Indian Institute of Science, Bangalore, India.
Rohini DattaMolecular Biophysics Unit, Indian Institute of Science, Bangalore, India.ORCID 0000-0003-2693-1922
Raghavan VaradarajanMolecular Biophysics Unit, Indian Institute of Science, Bangalore, India varadar@iisc.ac.in.ORCID 0000-0002-0823-7577
Indian Institute of Science Bangalore · INJawaharlal Nehru Centre for Advanced Scientific Research · IN

Funding

HIV-1 envelope structure, stability and dynamics probed by saturation mutagenesisR01AI118366 · NIAID · INDIAN INSTITUTE OF SCIENCE · PI VARADARAJAN, RAGHAVAN · 2015 to 2019
$607k
NIAID NIH HHS R01 AI118366
6 · The paper itself

Abstract

HIV-1 envelope (Env) glycoprotein gp160 exists as a trimer of heterodimers on the viral surface. In most structures of the soluble ectodomain of trimeric HIV-1 envelope glycoprotein, the regions from 512 to 517 of the fusion peptide and from 547 to 568 of the N-heptad repeat are disordered. We used aspartate scanning mutagenesis of subtype B strain JRFL Env as an alternate method to probe residue burial in the context of cleaved, cell surface-expressed Env, as buried residues should be intolerant to substitution with Asp. The data are inconsistent with a fully disordered 547 to 568 stretch, as residues 548, 549, 550, 555, 556, 559, 562, and 566 to 569 are all sensitive to Asp substitution. In the fusion peptide region, residues 513 and 515 were also sensitive to Asp substitution, suggesting that the fusion peptide may not be fully exposed in native Env. gp41 is metastable in the context of native trimer. Introduction of Asp at residues that are exposed in the prefusion state but buried in the postfusion state is expected to destabilize the postfusion state and any intermediate states where the residue is buried. We therefore performed soluble CD4 (sCD4)-induced gp120 shedding experiments to identify Asp mutants at residues 551, 554 to 559, 561 to 567, and 569 that could prevent gp120 shedding. We also observed similar mutational effects on shedding for equivalent mutants in the context of clade C Env from isolate 4-2J.41. These substitutions can potentially be used to stabilize native-like trimer derivatives that are used as HIV-1 vaccine immunogens.

Indexed as

Amino Acid SubstitutionAspartic AcidCD4 AntigensCloning, MolecularGene ExpressionGenetic VectorsHEK293 CellsHIV-1HIV Envelope Protein gp120HIV Envelope Protein gp160HIV Envelope Protein gp41HumansIntrinsically Disordered ProteinsMutagenesisProtein MultimerizationProtein StabilityAspartic AcidCD4 Antigensgp120 protein, Human immunodeficiency virus 1gp160 protein, Human immunodeficiency virus 1gp41 protein, Human immunodeficiency virus 1HIV Envelope Protein gp120HIV Envelope Protein gp160HIV Envelope Protein gp41Intrinsically Disordered ProteinsRecombinant Proteinsrecombinant soluble CD4charge burialelectrostaticsfusion mechanismimmunogen designprotein stabilityvaccine

Identifiers

PMID32817217
PMCPMC7565623
OpenAlexW3063568122

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.